Results 61 to 70 of about 175,728,522 (204)
ABSTRACT Background Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.
Weibin Liu +9 more
wiley +1 more source
Supplemental Material, sj-pdf-2-ccx-10.1177_10732748211066309 for Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study by Sihan Wang, Liubo Chen, Dongdong ...
Dongdong Chen (415068) +6 more
core +1 more source
ABSTRACT Background Hypoalbuminemia has been recognized as a characteristic adverse event associated with zolbetuximab plus chemotherapy in the treatment of claudin 18.2‐positive advanced gastric cancer. However, its incidence, clinical predictors, and management in real‐world settings remain unclear.
Taro Mizuno +11 more
wiley +1 more source
The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
Background: Esophagogastric junction adenocarcinoma (EJA) is one of the most common malignant tumors of digestive tract with high mortality worldwide. Given a lack of early diagnosis biomarkers, the prognosis of EJA is poor.
Zheng Li BS +9 more
doaj +1 more source
(A) Overview of the study population and schematic illustration showing tumor‐derived apoptotic and metabolic biomarkers, Apo10 and TKTL1, being phagocytosed by circulating monocytes and subsequently detected in peripheral blood. (B) Illustration of the epitope detection in monocytes (EDIM) strategy, using a flow‐cytometric gating approach based on ...
Zhiying Mao +8 more
wiley +1 more source
Precision Surgical Therapy for Adenocarcinoma of the Esophagus and Esophagogastric Junction
To facilitate the initial clinical decision regarding whether to use esophagectomy alone or neoadjuvant therapy in surgical care for individual patients with adenocarcinoma of the esophagus and esophagogastric junction—information not available from ...
Lu, Min +3 more
core +1 more source
Expression analysis of the TGF-β/SMAD target genes in adenocarcinoma of esophagogastric junction
The TGF-β/SMAD signaling pathway is found to play pivotal roles in cell growth, differentiation and tumorigenesis. Its target genes are closely related to the biological behaviors of some malignancies.
Peng Defeng, Fu Lin, Sun Guoping
doaj +1 more source
Is Adenocarcinoma of the Esophagogastric Junction or Cardia Different From Barrett Adenocarcinoma?
Abstract Over time the relative distribution of cancers of the proximal digestive tract has changed. Squamous cell carcinomas of the esophagus have become less common, while numbers of adenocarcinomas have greatly increased.
Nadine, Ectors +4 more
openaire +2 more sources
Adenosquamous carcinoma of the esophagogastric junction. Case report [PDF]
Adenosquamous carcinoma is a rare tumor with coexisting elements of infiltrating squamous cell carcinoma and adenocarcinoma. This tumor is reported to arise in different organs but rarely in the oesophagus.
De Giacomo, Tiziano +7 more
core +1 more source
ABSTRACT Aim The optimal surgical strategy and extent of lymph node (LN) dissection for clinical Stage I (cStage I) adenocarcinoma of the esophagogastric junction (AEG) remain controversial. This study aimed to evaluate surgical outcomes and clarify the prevalence and distribution of LN metastasis according to tumor characteristics in cStage I Siewert ...
Masayoshi Terayama +9 more
wiley +1 more source

